糖尿病患者发生低血糖:糖尿病治疗的负面影响。一项以患者为中心的综述

Translated title of the contribution: Hypoglycemia in diabetes: The dark side of diabetes treatment. A patient-centered review

Brianna Johnson-Rabbett, Elizabeth R. Seaquist

Research output: Contribution to journalReview article

3 Scopus citations

Abstract

Hypoglycemia is a frequent occurrence in patients with diabetes who are treated with insulin and insulin secretagogues. Hypoglycemia is the limiting factor that prevents patients from achieving the glycemic control known to reduce the microvascular complications of diabetes. Recurrent episodes of hypoglycemia can lead to impaired awareness of hypoglycemia where the first symptom of a low blood sugar is unconsciousness. The fear of hypoglycemia has a significant effect on the quality of life of patients and their families. In the acute setting, hypoglycemia can kill, and clinical trials have demonstrated that a single episode of severe hypoglycemia increases the risk of subsequent mortality and cardiovascular events. Clinicians must make efforts to recognize and prevent hypoglycemia in order to prevent the adverse events associated with this event. Patient education is central to these efforts. Recent developments in glucose monitoring and drug development have provided more approaches that can be used to reduce the risk of hypoglycemia in patients with diabetes.

Translated title of the contributionHypoglycemia in diabetes: The dark side of diabetes treatment. A patient-centered review
Original languageChinese
Pages (from-to)711-718
Number of pages8
JournalJournal of Diabetes
Volume11
Issue number9
DOIs
StatePublished - Jan 1 2019

Keywords

  • cardiovascular disease
  • diabetes
  • hypoglycemia
  • insulin
  • mortality

PubMed: MeSH publication types

  • Journal Article
  • Review

Fingerprint Dive into the research topics of 'Hypoglycemia in diabetes: The dark side of diabetes treatment. A patient-centered review'. Together they form a unique fingerprint.

  • Cite this